CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 8-K Event Material agreement
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 2,499,499 shares (conversion)
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Bylaws or fiscal year change · Other events
- 4 Conversion Director acquired 869,964 shares (conversion)
- 4 Open-market buy Director bought 425,926 shares at $13.50 ($5,750,001)
- 4 Conversion Former 10% Owner acquired 2,867,426 shares (conversion)
- 4 Option exercise Director acquired 26,505 shares (option exercise)
- 4 Conversion See Remarks acquired 107,875 shares (conversion)
- 4 Conversion Director acquired 2,500,920 shares (conversion)
- 4 Conversion Chief Medical Officer acquired 26,791 shares (conversion)
- 4 Option exercise Chief Scientific Officer acquired 239,952 shares (option exercise)
- 4 Open-market buy Former 10% Owner bought 164,963 shares at $13.50 ($2,227,001)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 44 of 47 · 923 filings